CXCR4 chemokine receptor expression in tumor tissue as an additional predictor factor for patients with colon cancer
- Authors: Orlova R.V1,2,3, Ivanova A.K2, Raskin G.A4, Kutukova S.I2,5, Androsova A.V2, Erdniev S.P2, Zhukova N.V1,2, Belyak N.P1,2, Popova N.V2, Avramenko I.V2, Antimonik N.Y.2, Zorina E.Y.2
-
Affiliations:
- St. Petersburg State University
- City Clinical Oncology Dispensary
- Clinical Hospital № 122
- Russian Research Center for Radiology and Surgical Technologies n.a. Acad. A.M. Granov
- Pavlov First St. Petersburg State Medical University
- Issue: Vol 26, No 12 (2019)
- Pages: 44-49
- Section: Articles
- URL: https://journals.eco-vector.com/2073-4034/article/view/312339
- DOI: https://doi.org/10.18565/pharmateca.2019.12.44-49
- ID: 312339
Cite item
Abstract
Keywords
Full Text
About the authors
R. V Orlova
St. Petersburg State University; City Clinical Oncology Dispensary; Clinical Hospital № 122St. Petersburg, Russia
A. K Ivanova
City Clinical Oncology Dispensary
Email: oncolog.ivanova@yandex.ru
Oncologist, Department of Chemotherapy 56, Veteranov Avenue, St. Petersburg 198255, Russian Federation
G. A Raskin
Russian Research Center for Radiology and Surgical Technologies n.a. Acad. A.M. GranovSt. Petersburg, Russia
S. I Kutukova
City Clinical Oncology Dispensary; Pavlov First St. Petersburg State Medical UniversitySt. Petersburg, Russia
A. V Androsova
City Clinical Oncology DispensarySt. Petersburg, Russia
S. P Erdniev
City Clinical Oncology DispensarySt. Petersburg, Russia
N. V Zhukova
St. Petersburg State University; City Clinical Oncology DispensarySt. Petersburg, Russia
N. P Belyak
St. Petersburg State University; City Clinical Oncology DispensarySt. Petersburg, Russia
N. V Popova
City Clinical Oncology DispensarySt. Petersburg, Russia
I. V Avramenko
City Clinical Oncology DispensarySt. Petersburg, Russia
N. Yu Antimonik
City Clinical Oncology DispensarySt. Petersburg, Russia
E. Yu Zorina
City Clinical Oncology DispensarySt. Petersburg, Russia
References
- Каприн А.Д., Старинский В.В., Петрова Г В. Состояние онкологической помощи населению России в 2016 г. М., 2017. 157 с
- Практические рекомендации по лечению злокачественных опухолей Российского общества клинической онкологии, версия. 2017. М., С. 261-64
- Sargent D.J., Marsoni S., Monges G., et al. Defective mismatch repair as a predictive marker for lack of efficacy of fluorouracil-based adjuvant therapy in colon cancer. J Clin Oncol. 2010;28(30):4664.
- Masahiro Kato, Joji Kitayama, Shinsuke Kazama, Hirokazu Nagawa. Expression pattern of CXC chemokine receptor-4 is correlated with lymph node metastasis in human invasive ductal carcinoma. Breast Cancer Research. 2003;5(5):R144-R150.
- Чердынцева Н.В., Гервас П.А., Литвяков Н.В. и др. Хемокины и прогрессия злокачественных новообразований. Медицинская иммунология. 2006;8(2-3):355-56
- Симбирцев А.С. Цитокины: классификация и биологические функции. Цитокины и воспаление. 2004;3(2):16-22
- Strieter R.M., Polverini P.J., Kunkel S.L., et al. The functional role of the ELR motif in CXC chemokine-mediated angiogenesis. J Biol Chem. 1995;270(45):27348-57. Doi:10.1074/ jbc.270.45.27348.
- Rivera C.G., Bader J.S., Popel A.S. Angiogenesis-associated crosstalk between collagens, CXC chemokines, and thrombospondin domain-containing proteins. Ann Biomed Eng. 2011;39(8):2213-22. doi: 10.1007/s10439-011-0325-2.
- Бережная Н.М., Чехун В.Ф. Иммунология злокачественного роста. Киев, 2005.
- Yu X., Wang D., Wang X., et al. CXCL12/CXCR4 promotes inflammation-driven colorectal cancer progression through activation of RhoA signaling by sponging miR-133a-3p. J Exp Clin Cancer Res. 2019;38(1):32. doi: 10.1186/s13046-018- 1014-x.
- Kim J., Mori T., Chen S.L., et al. Chemokine receptor CXCR4 expression in patients with melanoma and colorectal cancer liver metastases and the association with disease outcome. Ann Surg. 2006;244(1):113-20. doi: 10.1097/01. sla.0000217690.65909.9c